TERN-501

N/A

Report date: 2025/02/14 20:00:40
NME

Base Information

Drug NameTERN-501
Drug Alias NameTERN-501TERN 501
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionThyroid hormone receptor beta agonists
TargetsThyroid hormone receptor beta
Therapy Area/IndicationsObesityMetabolic Dysfunction-Associated Steatotic Liver Disease
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPhase 2 Clinical
Highest Status in ChinaN/A
Originator CompaniesShanghai Terns Biological Technology Co Ltd
China Registration ClassN/A

Develop Information

Active CompaniesShanghai Terns Biological Technology Co Ltd
Inactive CompaniesN/A
Active IndicationsObesityMetabolic Dysfunction-Associated Steatotic Liver Disease
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A